Boditech Med obtains approval in Korea for AFIAS infliximab

May 5, 2022

Korea Biomedical Review reported that Boditech Med has obtained approval in Korea for its AFIAS infliximab system. AFIAS infliximab is a therapeutic drug monitoring device used to measure infliximab levels in the blood and check for adverse reactions.

Print Page Mail Article